At Klinic, we recognize that diabetes and weight management are unique journeys for everyone, and we provide personalized care to help you achieve your goals
Longer term safety of dipeptidyl peptidase4 inhibitors in patients with type 2 diabetes mellitus: systematic review and metaanalysis
Nagashima, M
(The very first GLP-1 drug on the market, exenatide, had to be injected twice a day when it was released, in 2005the field has come a long way.) The medications are also given at levels much higher than natural GLP-1 ever reaches in the bloodstream
The main limitations of the study are the lack of a control group, the single-center design, and the low sample size, which, although statistically adequate, does not allow for a more in-depth analysis of muscle mass stratified by patient gender
[1] It is particularly common in certain parts of Africa, Asia, the Mediterranean, and the Middle East